Proteo Inc./Proteo Biotech AG - Minapharm/Rhein Minapharm Biogenetics SAE: Proteo Biotech AG, Germany and Minapharm, Egypt Enter into Development and License Agreement for Elafin
IRVINE, Calif./KIEL, Germany/CAIRO, Egypt--(BUSINESS WIRE)--Proteo, Inc. (OTCBB: PTEO; Frankfurt Freiverkehr: WKN: 925981) and its wholly-owned subsidiary Proteo Biotech AG together with Minapharm Pharmaceuticals SAE (Cairo and Alexandria Stock Exchange: MIPH) and its subsidiary Rhein Minapharm Biogenetics SAE announced today: